Download PDF
Deutsche Zeitschrift für Onkologie 2020; 52(02): 51-56
DOI: 10.1055/a-1162-2469
Forschung

Immunrelevante Mikronährstoffe bei viralen Atemwegsinfektionen

Immune-relevant Micronutrients for Viral Respiratory Infections
Uwe Gröber
1   AMM – Akademie für Mikronährstoffmedizin, Essen
,
Peter Holzhauer
1   AMM – Akademie für Mikronährstoffmedizin, Essen
2   Onkologisches Kompetenzzentrum Klinik Bad Trissl, Oberaudorf
,
Klaus Kisters
1   AMM – Akademie für Mikronährstoffmedizin, Essen
3   Medizinische Klinik I, St. Anna Hospital, Herne
› Author Affiliations
› Further Information
    Permissions and Reprints

ZUSAMMENFASSUNG

Ende 2019 nahm eine neue Coronavirus-Pandemie in der chinesischen Stadt Wuhan in der Provinz Hubei ihren Lauf. Der klinische Verlauf der durch SARS-CoV-2 ausgelösten Lungenerkrankung Covid-19 ist unterschiedlich. Einige Infizierte entwickeln nur leichte oder überhaupt keine Symptome. Bei anderen kommt es rasch zu einem akuten Lungenversagen und zum Tod. Über 80% der Covid-19-Erkrankungen treten bei älteren Menschen (±70 Jahre) mit Grunderkrankungen auf, wie KHK, Krebs, Diabetes mellitus oder zerebrovaskulären Veränderungen (z. B. Demenz). Neben entsprechenden Hygienemaßnahmen, dem individuellen Sozialverhalten, erfolgt derzeit über die Medien kein Hinweis auf die physiologische Bedeutung immunrelevanter Mikronährstoffe, mit der das Immunsystem gegen virale Atemwegserkrankungen unterstützt und Begleitkomplikationen verringert werden könnten. Deshalb sollte bei Covid-19-Patienten grundsätzlich nicht nur der Makonährstoff-, sondern auch der Mikronährstoff-Status labordiagnostisch objektiviert (z. B. 25(OH)D, Selen, Omega-3-Index) und gegebenenfalls gezielt kompensiert werden.

ABSTRACT

Worldwide the pandemic of Covid-19 spreads rapidly and has an enormous public health impact with substantial fatal outcomes especially in high-risk groups, such as older people and patients with comorbidities like diabetes, dementia or cancer. In the absence of a vaccine against Covid-19 there is an urgent need to find supportive therapies that can stabilize the immune system and can help to deal with the infection. As is well known the incidence of malnutrition in German geriatric clinics ranges up to 60% among the hospitalized elderly population. The nutritional (=macro- and micronutrient) status of each infected patient should be evaluated before the administration of general treatments. In this context the role of immune-relevant micronutrients, such as vitamin D, retinol, vitamin C, selenium and zinc is of special importance. The laboratory assessment of 25(OH)D, selenium or omega-3-index is therefore mandatory. Micronutrient deficiencies should be right away compensated by individual supplementation.

Schlüsselwörter

Mangelernährung - Immunsystem - Mikronährstoffe - Vitamin D - 25(OH)D - Retinol - Vitamin C - Selen - Zink - Omega-3-Fettsäuren

Key words

Malnutrition - immune system - micronutrients - vitamin D - 25(OH)D - retinol - vitamin C - selenium - zinc - omega-3 fatty acids


Publication History

Article published online:
28 June 2020

© Georg Thieme Verlag KG
Stuttgart · New York

 

  • Literatur

  • 1 Biesalski HK, Bischoff SC. Hrsg Ernährungsmedizin. Nach dem Curriculum Ernährungsmedizin der Bundesärztekammer. 4. Aufl.. Stuttgart: Thieme; 2010
    CrossrefGoogle Scholar
  • 2 Li Q, Guan X, Wu P. et al. Early transmission dynamics in Wuhan, China, of novel Coronavirus-infected pneumonia. N Engl J Med 2020; 382: 1199-1207
    CrossrefPubMedGoogle Scholar
  • 3 Deutschlandfunk: Covid-19 RKI: Corona-Tote in Deutschland derzeit im Durchschnitt 82 Jahre alt, vom 09 April 2020
    PubMed
  • 4 Küpper C. Mangelernährung im Alter. Ernährungs Umschau 2010; 57: 256-262
    PubMedGoogle Scholar
  • 5 Katsanos CS, Kobayashi H, Sheffield-Moore M. et al. Aging is associated with diminished accretion of muscle proteins after the ingestion of a small bolus of essential amino acids. Am J Clin Nutr 2005; 82: 1065-1073
    CrossrefPubMedGoogle Scholar
  • 6 Diekmann R, Bauer J. Proteinbedarf älterer Menschen. DMW – Deutsche Medizinische Wochenschrift 2014; 139: 239-242
    PubMedGoogle Scholar
  • 7 Pennings B, Boirie Y, Senden JM. et al. Whey protein stimulates postprandial muscle protein accretion more effectively than do casein and casein hydrolysate in older men. Am J Clin Nutr 2011; 93: 997-1005
    CrossrefPubMedGoogle Scholar
  • 8 Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-281
    CrossrefPubMedGoogle Scholar
  • 9 Gröber U, Holick MF. Vitamin D: Die Heilkraft des Sonnenvitamins. Stuttgart: Wissenschaftl. Verlagsges; 2020
    PubMedGoogle Scholar
  • 10 Cashman KD, Dowling KG, Škrabáková Z. et al. Vitamin D deficiency in Europe: pandemic?. Am J Clin Nutr 2016; 103: 1033-1044
    CrossrefPubMedGoogle Scholar
  • 11 Bundesministerium für Ernährung, Landwirtschaft und Verbraucherschutz Nationale Verzehrsstudie II. Max Rubner-Institut; 2008
    PubMed
  • 12 Imdad A, Mayo-Wilson E, Herzer K. et al. Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age. Cochrane Database of Systematic Reviews 2017; Issue 3: CD008524 DOI: 10.1002/14651858.CD008524.pub3.
    CrossrefPubMedGoogle Scholar
  • 13 Jee J, Hoet AE, Azevedo MP. et al. Effects of dietary vitamin A content on antibody responses of feedlot calves inoculated intramuscularly with an inactivated bovine coronavirus vaccine. Am J Vet Res 2013; 74: 1353-1362
    CrossrefPubMedGoogle Scholar
  • 14 Trottier C, Colombo M, Mann KK. et al. Retinoids inhibit measles virus through a type I IFN-dependent bystander effect. FASEB J 2009; 23: 3203-3212
    CrossrefPubMedGoogle Scholar
  • 15 Patel N, Penkert RR, Jones BG. et al. Baseline serum vitamin A and D levels determine benefit of oral vitamin A&D supplements to humoral immune responses following pediatric influenza vaccination. Viruses 2019; 11: 907
    CrossrefPubMedGoogle Scholar
  • 16 Gruber-Bzura BM. Vitamin D and influenza – prevention or therapy?. Int J Mol Sci 2018; 19: 2419
    CrossrefPubMedGoogle Scholar
  • 17 Grant WB, Lahore H, McDonnell SL. et al. Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients 2020; 12: 988
    CrossrefPubMedGoogle Scholar
  • 18 Mousavi S, Bereswill S, Heimesaat MM. Immunomodulatory and antimicrobial effects of vitamin C. Eur J Microbiol Immunol (Bp) 2019; 9: 73-79
    CrossrefPubMedGoogle Scholar
  • 19 Colunga Biancatelli RML, Berrill M, Marik PE. The antiviral properties of vitamin C. Expert Rev Anti Infect Ther 2020; 18: 99-101
    CrossrefPubMedGoogle Scholar
  • 20 Elste V, Troesch B, Eggersdorfer M, Weber P. Emerging evidence on neutrophil motility supporting its usefulness to define vitamin C intake requirements. Nutrients 2017; 9: 503
    CrossrefPubMedGoogle Scholar
  • 21 Hemilä H. Vitamin C and SARS coronavirus. J Antimicrob Chemother 2003; 52: 1049-1050
    CrossrefPubMedGoogle Scholar
  • 22 Levine M, Conry-Cantilena C, Wang Y. et al. Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc Natl Acad Sci U S A 1996; 93: 3704-3709
    CrossrefPubMedGoogle Scholar
  • 23 Levine M, Wang Y, Padayatty SJ. et al. A new recommended dietary allowance of vitamin C for healthy young women. Proc Natl Acad Sci U S A 2001; 98: 9842-9846
    CrossrefPubMedGoogle Scholar
  • 24 Wang Y, Lin H, Lin BW. et al. Effects of different ascorbic acid doses on the mortality of critically ill patients: a meta-analysis. Ann Intensive Care 2019; 9: 58
    CrossrefPubMedGoogle Scholar
  • 25 Fowler AA, Truwit JD, Hite RD. et al. Effect of vitamin C infusion on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and severe acute respiratory failure: The CITRIS-ALI randomized clinical trial. JAMA 2019; 322: 1261-1270
    CrossrefPubMedGoogle Scholar
  • 26 Hemilä H, Chalker E. Vitamin C may reduce the duration of mechanical ventilation in critically ill patients: a meta-regression analysis. J Intensive Care 2020; 8: 15
    CrossrefPubMedGoogle Scholar
  • 27 ZhiYong Peng. Vitamin C infusion for the treatment of severe 2019-nCoV infected pneumonia: a prospective randomized clinical trial. ClinicalTrials.gov. 2020 ID: NCT04264533
    PubMedGoogle Scholar
  • 28 Shanghai Clinical Treatment Expert Group for corona virus disease 2019. Expert consensus statement from Shanghai. Chin J Infect Dis 2020; 38. doi: 10.3760/cma.j.issn.1000-6680.2020.0016. Direct translation of Shanghai management guideline for Covid-19: https://www. sepsis-en-daarna.nl/wp-content/uploads/2020/04/Shanghai-Management- Guideline-for-COVID-1.pdf
    PubMed
  • 29 Arabi YM, Fowler R, Hayden FG. Critical care management of adults with community-acquired severe respiratory viral infection. Intensive Care Med 2020; 46: 315-328
    CrossrefPubMedGoogle Scholar
  • 30 Jones GD, Droz B, Greve P. et al. Selenium deficiency risk predicted to increase under future climate change. Proc Natl Acad Sci U S A 2017; 114: 2848-2853
    CrossrefPubMedGoogle Scholar
  • 31 Yamashita Y, Yamashita M. Identification of a novel selenium containing compound, selenoneine, as the predominant chemical form of organic selenium in the blood of bluefin tuna. J Biol Chem 2010; 285: 18134-18138
    CrossrefPubMedGoogle Scholar
  • 32 Seko T, Yamamura S, Ishihara K. et al. Inhibition of angiotensin-converting enzyme by selenoneine. Fisheries Science 2019; 85: 731-736
    CrossrefPubMedGoogle Scholar
  • 33 Guillin OM, Vindry C, Ohlmann T. et al. Selenium, selenoproteins and viral infection. Nutrients 2019; 11: 2101
    CrossrefPubMedGoogle Scholar
  • 34 Steinbrenner H. et al. Dietary selenium in adjuvant therapy of viral and bacterial infections. Adv Nutr 2015; 6: 73-82
    CrossrefPubMedGoogle Scholar
  • 35 Nelson HK. et al. Host nutritional selenium status as a driving force for influenza virus mutations. FASEB J 2001; 15: 1846-1848
    CrossrefPubMedGoogle Scholar
  • 36 Zhang J, Li G, Liu X. et al. Influenza A virus M1 blocks the classical complement pathway through interacting with C1qA. J Gen Virol 2009; 90 (Pt 11): 2751-2758
    CrossrefPubMedGoogle Scholar
  • 37 Rayman MP. Selenium and human health. Lancet 2012; 379: 1256-1268
    CrossrefPubMedGoogle Scholar
  • 38 Classen HG, Gröber U, Kisters K. Zink – Das unterschätzte Element. Med Monatsschr Pharm 2020; 43: 149-158
    PubMedGoogle Scholar
  • 39 Read SA, Obeid S. et al. The role of zinc in antiviral immunity. Adv Nutr 2019; 10: 696-710
    CrossrefPubMedGoogle Scholar
  • 40 te Velthuis AJW, van den Worm SHE, Sims AC. et al. Zn(2+) inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture. PLoS Pathog 2010; 6: e1001176
    CrossrefPubMedGoogle Scholar
  • 41 Hemilä H, Haukka J, Alho M. et al. Zinc acetate lozenges for the treatment of the common cold: a randomised controlled trial. BMJ Open 2020; 10: e031662
    CrossrefPubMedGoogle Scholar
  • 42 Gröber U, Kisters K. Corona, Influenza & Co – Wie stärke ich mein Immunsystem mit Mikronährstoffen. Stuttgart: Wissenschaftl. Verlagsges; 2020
    PubMedGoogle Scholar
  • 43 Hemilä H, Chalker E. The effectiveness of high dose zinc acetate lozenges on various common cold symptoms: a meta-analysis. BMC Fam Pract 2015; 16: 24
    CrossrefPubMedGoogle Scholar